cGxP.wire https://validator.w3.org/feed/docs/rss2.html IMUNON Advances IMNN-001 Phase 2 After Favorable Safety Review Quoin Gains FDA Fast Track for QRX003 in Peeling Skin Syndrome Palisade Bio Gains FDA IND Clearance for PALI-2108 Polyrizon Enrolls First Patient in NASARIX U.S. Study Traferox Gains FDA Clearance for X°Port Heart System AIM Highlights Ampligen Potential in Pancreatic Cancer MAIA Advances Phase 3 Ateganosine Trial in Advanced NSCLC Ophirex Publishes Phase 2 BRAVIO Varespladib Data Seek Labs Launches Open Impact Program for Neglected Diseases Zealand Pharma Initiates Phase 3 ZUPREME Program for Petrelintide Roche Reports Positive Phase 3 Sefaxersen Data in IgAN Applied Biologics Completes CAMPX Patient Follow-Up OSE to Present Phase 2 Tedopi Data in Metastatic NSCLC Corcept Gains Positive CHMP Opinion for Lifyorli in Ovarian Cancer Daiichi Sankyo and AstraZeneca Gain EU Backing for Enhertu SystImmune Advances SI-B037 Into Phase 1/1b Trial Mercy BioAnalytics Advances Evident Ovarian Cancer Test Beactica Advances BEA-17 Toward Glioblastoma Trials Kelun-Biotech to Present Sac-TMT Phase 3 Data at ESMO 2026 AbbVie Wins EU Approval for RINVOQ in Pediatric JIA BoomRay, Novartis Sign Global License Deal for RLT Asset Opterion Health Advances OPT101 to Phase 2a After Phase 1 Akeso to Present Ivonescimab Phase 3 Data at ESMO 2026 AbbVie and Iambic Expand AI Drug Discovery Collaboration Smith+Nephew Showcases Shoulder Technologies at ICSES 2026 Johnson & Johnson Wins EU Approval for ICOTYDE in Psoriasis Moderna to Present Intismeran Data at ESMO 2026 NewAmsterdam Pharma Wins EU Approval for Ubeslo and Evlarco Q32 Bio to Present Bempikibart Data at EADV 2026 Co-Diagnostics Highlights Ebola Testing and Outbreak Innovation Arcturus to Present ARCT-810 Phase 2 OTC Deficiency Data Otsuka Reports Phase 3b SIMTRIYO Data in ADHD and Anxiety PureTech Gains FDA Fast Track for LYT-200 in HR-MDS Alkermes Reports Positive Phase 1b ADHD Data for ALKS 7290 Cue Biopharma Reports Positive Phase 2 CUE-221 Results Tiziana Completes INFORM-MS Phase 2a Trial of Intranasal Foralumab Beacon Therapeutics Reports Positive VISTA Data for Laru-zova Merck Gains Positive EU CHMP Opinion for KEYTRUDA and Padcev Abeona Congratulates Ultragenyx on FAYUVI FDA Approval Sensorium Reports Positive Phase 1a Data for SNTX-2643 Natera Reports Largest Lung Cancer MRD Study for Signatera Quest Diagnostics Finds High Tick-Borne Disease Co-Exposure IMPACT Therapeutics Gains Positive CHMP Opinion for Senaparib Nabsys Advances CRISPR Genome Mapping With New Study Johnson & Johnson Reports Positive CAPLYTA Phase 3 Mania Data Alfasigma Gains Positive CHMP Opinion for Filgotinib in axSpA Veeva Launches Falcon Router for AI Safety Reporting Merck Launches Your Hive of Whole Health for HIV Care Zealand Pharma Gains Positive CHMP Opinion for Zeydovio Puma Biotechnology Initiates ALISCA-Lung2 Phase II Trial